Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Hoth

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Cancer Treatment Reports|October 1, 1986
Central nervous system toxicity of fludarabine phosphateH G Chun, B R Leyland-Jones, S M Caryk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1986
Homoharringtonine--perspectives on an active new natural productP J O'Dwyer, S A King, D F Hoth, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Hypersensitivity reactions to deoxycoformycinP J O'Dwyer, S A King, E Eisenhauer, et al.
Cancer Treatment Reports|May 1, 1987
Indicine N-oxide: clinical use of a pyrrolizidine alkaloidS A King, M Suffness, B Leyland-Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1985
Dichloromethotrexate--a critical reassessmentP J O'Dwyer, B Leyland-Jones, M T Alonso, et al.
Cancer Treatment Reports|October 1, 1985
Site visit monitoring program of the clinical cooperative groups: results of the first 3 yearsJ K Mauer, D F Hoth, D K Macfarlane, et al.
Cancer Treatment Reports|July 1, 1987
Azacitidine: 10 years laterA B Glover, B R Leyland-Jones, H G Chun, et al.
Cancer Treatment Reports|December 1, 1987
Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acidJ L Grem, D F Hoth, J M Hamilton, et al.
Oncology (Williston Park, N.Y.)|June 1, 1988
Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemiaP J O'Dwyer, B D Cheson, B Leyland-Jones, et al.
Investigational New Drugs|December 1, 1988
Pyrazole: preclinical reassessmentP J O'Dwyer, S A King, J Plowman, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Cancer Treatment Reports|October 1, 1986
Central nervous system toxicity of fludarabine phosphateH G Chun, B R Leyland-Jones, S M Caryk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1986
Homoharringtonine--perspectives on an active new natural productP J O'Dwyer, S A King, D F Hoth, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Hypersensitivity reactions to deoxycoformycinP J O'Dwyer, S A King, E Eisenhauer, et al.
Cancer Treatment Reports|May 1, 1987
Indicine N-oxide: clinical use of a pyrrolizidine alkaloidS A King, M Suffness, B Leyland-Jones, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1985
Dichloromethotrexate--a critical reassessmentP J O'Dwyer, B Leyland-Jones, M T Alonso, et al.
Cancer Treatment Reports|October 1, 1985
Site visit monitoring program of the clinical cooperative groups: results of the first 3 yearsJ K Mauer, D F Hoth, D K Macfarlane, et al.
Cancer Treatment Reports|July 1, 1987
Azacitidine: 10 years laterA B Glover, B R Leyland-Jones, H G Chun, et al.
Cancer Treatment Reports|December 1, 1987
Overview of current status and future direction of clinical trials with 5-fluorouracil in combination with folinic acidJ L Grem, D F Hoth, J M Hamilton, et al.
Oncology (Williston Park, N.Y.)|June 1, 1988
Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemiaP J O'Dwyer, B D Cheson, B Leyland-Jones, et al.
Investigational New Drugs|December 1, 1988
Pyrazole: preclinical reassessmentP J O'Dwyer, S A King, J Plowman, et al.
Pageof 5